DDI Between BI Empagliflozin (10773) and Verapamil

NCT01276301 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Verapamil
DRUG: BI 10773
DRUG: BI 10773

Sponsor

Boehringer Ingelheim